Clinical trial Recruiting at 1 site Interventional Ages 20 to 75

HOBSCOTCH-MS: Home-based telehealth cognitive coaching for people with multiple sclerosis

Official title: HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS) - Efficacy Trial

Run by Dartmouth-Hitchcock Medical Center · NCT06951919 · Data updated 2026-11-12

This program will test whether a home-based telehealth cognitive coaching program (HOBSCOTCH-MS) can improve thinking, memory, and quality of life for people with MS and reduce caregiver burden.

Quick facts

Study typeInterventional
Ages20 Years to 75 Years
SexAll
Enrollment125 (estimated)
SponsorDartmouth-Hitchcock Medical Center
Academic / other
Locations1 site (Lebanon, New Hampshire)
StatusRecruiting
StartedSeptember 9, 2025
Main results expectedMay 2028
Study endsDecember 2028
Registry record updatedNovember 2, 2026
Trial IDNCT06951919 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 20–75 with relapsing or progressive MS who report cognitive or memory problems, have at least a high school education, are fluent in English, and have reliable internet and telephone access are the intended participants.

Probably not a fit

People with active severe psychiatric disorders, other neurological illnesses that affect cognition, diagnosed developmental or intellectual disorders, or without internet/telephone access or English fluency are unlikely to be eligible or to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

HOBSCOTCH-MS delivers one-on-one virtual sessions with a certified cognitive coach, starting with a preparatory session followed by eight weekly 45–60 minute sessions focused on self-management, memory strategies, and cognitive training. People with MS are randomized to begin the program immediately or after a three-month waitlist, and optional caregivers may enroll alongside the person with MS. Participants are followed for about six months and will complete measures of quality of life, subjective and objective cognition, problem-solving, self-efficacy, and mood, with caregiver burden and knowledge also tracked. The study will examine which baseline factors predict benefit and whether changes in problem-solving and self-efficacy mediate cognitive and quality-of-life outcomes.

Why it matters

Potential benefit: If effective, HOBSCOTCH-MS could improve everyday thinking and memory, raise quality of life for people with MS, and reduce caregiver stress.

How similar studies have gone: Previous HOBSCOTCH programs and other telehealth cognitive rehabilitation trials have shown promising improvements in subjective cognition and quality of life in small studies, but large randomized MS-specific evidence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Inclusion Criteria - MS Participant

  * Age 20 - 75 years
  * Diagnosis of relapsing or progressive MS
  * Education of at least Grade 12 or GED
  * Fluent in English
  * Subjective cognitive and memory challenges
  * Internet access
  * Telephone access

Inclusion Criteria - Caregiver Participant

* 20 years +
* Fluent in English
* Caregiver to a MS Participant
* Participant MS has given permission to Caregiver to enroll with them
* Internet access
* Telephone access

Exclusion Criteria:

* Exclusion Criteria MS Participant

  * Current diagnosed psychiatric disorders (e.g., schizophrenia, bipolar disorder or substance use disorder).
  * Other neurological disorder such as epilepsy, brain tumor, severe brain injury or mild to moderate brain injury with a history of 30 or more minutes' loss of consciousness, or other disorder that would confound the focus on MS
  * Diagnosed developmental attention, learning, or intellectual disorder; sensory, motor, or physical disability that would prevent engagement with the intervention or render the person unable complete study outcome measures
  * Exacerbation of MS symptoms (relapse) or ongoing steroid treatment within three months of study enrollment
  * Significant visual impairment precluding reading or writing
  * Lack of access to the technical resources (e.g., internet access, telephone) required for participation

Exclusion Criteria - Caregiver Participant

* Significant visual impairment precluding reading or writing
* No reliable telephone or internet access

Where it's running

  • Dartmouth-Health Lebanon
    Lebanon, New Hampshire, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.